Lilly’s retatrutide meets endpoints in two phase 3 obesity trials

Markets Investing.com By Investing.com 23 Jul 2026 10:48 1 min read

Lilly’s retatrutide meets endpoints in two phase 3 obesity trials

Lilly’s retatrutide meets endpoints in two phase 3 obesity trials

Lilly’s retatrutide meets endpoints in two phase 3 obesity trials

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.